Trial · NCT07900334
Study of Thyroid Dysfunction in Immune Thrombocytopenic Purpura Patients
NCT07900334, Not yet recruiting, Sohag University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study of Thyroid Dysfunction in Immune Thrombocytopenic Purpura Patients. Trials, record NCT07900334. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07900334
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study of Thyroid Dysfunction in Immune Thrombocytopenic Purpura Patients
- NCT number
- NCT07900334
- Status
- Not yet recruiting
- Enrollment
- 50 participants, estimated
- Lead sponsor
- Sohag University
- Conditions
- Thyroid Dysfunction, Immune Thrombocytopenic Purpura
- Interventions
- Laboratory tests TSH, FT3, FT4 ,anti thyroglobulin antibodies, Anti -TPO antibodies
- First posted
- 2026-10-28
- Last updated
- 2026-10-28
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Prevalence of thyroid dysfunction in patients with immune thrombocytopenia (ITP) | At baseline, during the initial study assessment. | The prevalence of thyroid dysfunction among patients with newly diagnosed immune thrombocytopenia (ITP) will be assessed using serum thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), and free thyroxine (FT4) levels. Thyroid function will be classified according to the laboratory reference ranges. The number and percentage of patients with abnormal thyroid function will be reported. |
| Secondary | Comparison of serum thyroid function test levels between patients with ITP and healthy controls | At baseline, during the initial study assessment. | Serum TSH, FT3, and FT4 levels will be measured and compared between patients with newly diagnosed immune thrombocytopenia (ITP) and age- and sex-matched healthy controls. Results will be summarized using appropriate descriptive statistics. |
| Secondary | Prevalence of thyroid autoantibody positivity in patients with ITP and healthy controls | At baseline, during the initial study assessment. | Serum anti-thyroid peroxidase antibodies (Anti-TPO) and anti-thyroglobulin antibodies (Anti-TG) will be measured in both study groups. The number and percentage of participants with positive thyroid autoantibodies will be determined according to the laboratory-specific reference ranges and compared between patients with ITP and healthy controls. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07900334
GET https://conductscience.org/api/trials/v1/NCT07900334/registered